These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 11907786

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Acute profound thrombocytopenia following C7E3 Fab (Abciximab) therapy: case reports, review of the literature and implications for therapy.
    Jubelirer SJ, Koenig BA, Bates MC.
    Am J Hematol; 1999 Jul; 61(3):205-8. PubMed ID: 10398314
    [Abstract] [Full Text] [Related]

  • 23. Abciximab readministration.
    Orford JL, Holmes DR.
    Rev Cardiovasc Med; 2002 Jul; 3(2):67-70. PubMed ID: 12447149
    [Abstract] [Full Text] [Related]

  • 24. Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial.
    Greenbaum AB, Grines CL, Bittl JA, Becker RC, Kereiakes DJ, Gilchrist IC, Clegg J, Stankowski JE, Grogan DR, Harrington RA, Emanuelsson H, Weaver WD.
    Am Heart J; 2006 Mar; 151(3):689.e1-689.e10. PubMed ID: 16504633
    [Abstract] [Full Text] [Related]

  • 25. Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors.
    Kleiman NS, Raizner AE, Jordan R, Wang AL, Norton D, Mace KF, Joshi A, Coller BS, Weisman HF.
    J Am Coll Cardiol; 1995 Dec; 26(7):1665-71. PubMed ID: 7594101
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Abciximab-induced acute profound thrombocytopenia postpercutaneous coronary intervention.
    Golden T, Ghazala S, Wadeea R, Junna S.
    BMJ Case Rep; 2017 Jul 14; 2017():. PubMed ID: 28710245
    [Abstract] [Full Text] [Related]

  • 28. Predictors of bleeding complications and thrombocytopenia with the use of abciximab during percutaneous coronary intervention.
    Razakjr OA, Tan HC, Yip WL, Lim YT.
    J Interv Cardiol; 2005 Feb 14; 18(1):33-7. PubMed ID: 15788052
    [Abstract] [Full Text] [Related]

  • 29. The importance of differentiating ReoPro (c7E3 abciximab) induced thrombocytopenia from heparin-induced thrombocytopenia.
    Davidson SJ, Turner N, Clague JR, Oldershaw PJ, Burman JF.
    Thromb Haemost; 1999 Nov 14; 82(5):1560-1. PubMed ID: 10595660
    [No Abstract] [Full Text] [Related]

  • 30. Safety and efficacy of the platelet glycoprotein IIb/IIIa inhibitor abciximab in Chinese patients undergoing high-risk angioplasty.
    Chen YH, Chen JW, Wu TC, Ding PY, Wang SP, Chang MS.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Jan 14; 63(1):8-15. PubMed ID: 10645045
    [Abstract] [Full Text] [Related]

  • 31. Safety, inhibition of platelet aggregation and pharmacokinetics of Fab'2 fragments of the anti-glycoprotein IIb-IIIa monoclonal antibody FRaMon in high-risk coronary angioplasty.
    Mazurov AV, Pevzner DV, Antonova OA, Byzova TV, Khaspekova SG, Semenov AV, Vlasik TN, Samko AN, Staroverov II, Ruda MY.
    Platelets; 2002 Dec 14; 13(8):465-77. PubMed ID: 12487780
    [Abstract] [Full Text] [Related]

  • 32. Acute severe thrombocytopenia after treatment with ReoPro (abciximab).
    Butler R, Hubner PJ.
    Heart; 2000 Apr 14; 83(4):E5. PubMed ID: 10722557
    [Abstract] [Full Text] [Related]

  • 33. Thrombocytopenia and glycoprotein IIb-IIIa receptor antagonists.
    Stiegler HM, Fischer Y, Steiner S.
    Lancet; 1999 Apr 03; 353(9159):1185. PubMed ID: 10210005
    [No Abstract] [Full Text] [Related]

  • 34. A randomized study comparing same-day home discharge and abciximab bolus only to overnight hospitalization and abciximab bolus and infusion after transradial coronary stent implantation.
    Bertrand OF, De Larochellière R, Rodés-Cabau J, Proulx G, Gleeton O, Nguyen CM, Déry JP, Barbeau G, Noël B, Larose E, Poirier P, Roy L, Early Discharge After Transradial Stenting of Coronary Arteries Study Investigators.
    Circulation; 2006 Dec 12; 114(24):2636-43. PubMed ID: 17145988
    [Abstract] [Full Text] [Related]

  • 35. Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial.
    Marmur JD, Mitre CA, Barnathan E, Cavusoglu E.
    Am Heart J; 2006 Nov 12; 152(5):876-81. PubMed ID: 17070148
    [Abstract] [Full Text] [Related]

  • 36. Profound delayed thrombocytopenia presenting 16 days after Abciximab (Reopro®) administration.
    Webb GJ, Swinburn JM, Grech H.
    Platelets; 2011 Nov 12; 22(4):302-4. PubMed ID: 21526887
    [Abstract] [Full Text] [Related]

  • 37. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
    Lincoff AM, Califf RM, Moliterno DJ, Ellis SG, Ducas J, Kramer JH, Kleiman NS, Cohen EA, Booth JE, Sapp SK, Cabot CF, Topol EJ.
    N Engl J Med; 1999 Jul 29; 341(5):319-27. PubMed ID: 10423466
    [Abstract] [Full Text] [Related]

  • 38. Severe delayed thrombocytopenia associated with abciximab (ReoPro) therapy.
    Reddy MS, Carmody TJ, Kereiakes DJ.
    Catheter Cardiovasc Interv; 2001 Apr 29; 52(4):486-8. PubMed ID: 11285605
    [Abstract] [Full Text] [Related]

  • 39. Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS.
    Lenderink T, Boersma E, Ruzyllo W, Widimsky P, Ohman EM, Armstrong PW, Wallentin L, Simoons ML, GUSTO IV-ACS Investigators.
    Am Heart J; 2004 May 29; 147(5):865-73. PubMed ID: 15131544
    [Abstract] [Full Text] [Related]

  • 40. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators.
    Hamm CW, Heeschen C, Goldmann B, Vahanian A, Adgey J, Miguel CM, Rutsch W, Berger J, Kootstra J, Simoons ML.
    N Engl J Med; 1999 May 27; 340(21):1623-9. PubMed ID: 10341274
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.